Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsKamolika Roy
Clinical InstructorAbout
Research
Publications
2023
Impact of Social Isolation and Loneliness in Older Adults: Current Understanding and Future Directions
Roy K, Smilowitz S, Bhatt S, Conroy M. Impact of Social Isolation and Loneliness in Older Adults: Current Understanding and Future Directions. Current Geriatrics Reports 2023, 12: 138-148. DOI: 10.1007/s13670-023-00393-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2022
COVID-19 Brain Effects
Dix E, Roy K. COVID-19 Brain Effects. Psychiatric Clinics Of North America 2022, 45: 625-637. PMID: 36396269, PMCID: PMC9257090, DOI: 10.1016/j.psc.2022.07.009.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsbrain effectssevere acute respiratory syndrome coronavirus 2acute respiratory syndrome coronavirus 2respiratory syndrome coronavirus 2post-acute phasesyndrome coronavirus 2burden of diseaseCOVID-19development of interventionsneuropsychiatric symptomscoronavirus 2high riskcoronavirus diseasenovel coronavirusbraindiseasecomplicationspathogenesisetiologyillnesssymptoms
2015
Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?
Bass B, Upson S, Roy K, Montgomery E, Jalonen T, Murray I. Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease? Neural Regeneration Research 2015, 10: 1023-1025. PMID: 26330810, PMCID: PMC4541218, DOI: 10.4103/1673-5374.160059.Peer-Reviewed Original Research
2014
Regional Fluorodeoxyglucose Metabolism and Instrumental Activities of Daily Living across the Alzheimer's Disease Spectrum
Roy K, Pepin L, Philiossaint M, Lorius N, Becker J, Locascio J, Rentz D, Sperling R, Johnson K, Marshall G, Initiative F. Regional Fluorodeoxyglucose Metabolism and Instrumental Activities of Daily Living across the Alzheimer's Disease Spectrum. Journal Of Alzheimer’s Disease 2014, 42: 291-300. PMID: 24898635, PMCID: PMC4133312, DOI: 10.3233/jad-131796.Peer-Reviewed Original ResearchActivities of Daily LivingAgedAged, 80 and overAlzheimer DiseaseBrainBrain MappingCognitive DysfunctionCross-Sectional StudiesDatabases, FactualDisease ProgressionFemaleFluorodeoxyglucose F18Follow-Up StudiesHumansLongitudinal StudiesMaleMiddle AgedPositron-Emission TomographyRadiopharmaceuticalsSurveys and QuestionnairesP1‐180: A NEW PERFORMANCE‐BASED ACTIVITIES OF DAILY LIVING INSTRUMENT FOR EARLY ALZHEIMER'S DISEASE
Marshall G, Dekhtyar M, Bruno J, Roy K, Masters C, Jethwani K, Amariglio R, Johnson K, Sperling R, Rentz D. P1‐180: A NEW PERFORMANCE‐BASED ACTIVITIES OF DAILY LIVING INSTRUMENT FOR EARLY ALZHEIMER'S DISEASE. Alzheimer's & Dementia 2014, 10: p365-p365. DOI: 10.1016/j.jalz.2014.05.418.Peer-Reviewed Original ResearchDevelopment of a Psychometrically Equivalent Short Form of the Face–Name Associative Memory Exam for use Along the Early Alzheimer’s Disease Trajectory
Papp K, Amariglio R, Dekhtyar M, Roy K, Wigman S, Bamfo R, Sherman J, Sperling R, Rentz D. Development of a Psychometrically Equivalent Short Form of the Face–Name Associative Memory Exam for use Along the Early Alzheimer’s Disease Trajectory. The Clinical Neuropsychologist 2014, 28: 771-785. PMID: 24815535, PMCID: PMC4134419, DOI: 10.1080/13854046.2014.911351.Peer-Reviewed Original Research
2011
Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis
Stein L, Roy K, Lei L, Kaushal S. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis. Expert Opinion On Biological Therapy 2011, 11: 429-439. PMID: 21299439, DOI: 10.1517/14712598.2011.557358.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2010
Ocular Gene Therapy: An Evaluation of Recombinant Adeno-Associated Virus-Mediated Gene Therapy Interventions for the Treatment of Ocular Disease
Roy K, Stein L, Kaushal S. Ocular Gene Therapy: An Evaluation of Recombinant Adeno-Associated Virus-Mediated Gene Therapy Interventions for the Treatment of Ocular Disease. Human Gene Therapy 2010, 21: 915-927. PMID: 20384478, DOI: 10.1089/hum.2010.041.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsOcular Gene Therapy: An Evaluation of RAAV-mediated Gene Therapy Interventions for the Treatment of Ocular Disease
Stein L, Kaushal S, Roy K. Ocular Gene Therapy: An Evaluation of RAAV-mediated Gene Therapy Interventions for the Treatment of Ocular Disease. 2010, 663-663. DOI: 10.5005/jp/books/11238_41.Books